| |JULY 20268TOP STORIESHEART FUNCTION MAY HOLD THE KEY TO EARLY ALZHEIMER'S DETECTIONWEIGHT LOSS PILLS RACE HEATS UP AS NEW RIVALS CHALLENGE BIG PHARMAAI HEALTHCARE GROWTH PUTS INDIA AT THE CENTER OF INNOVATIONRELIANCE'S LATEST PATENT BRINGS EARLY CANCER DETECTION CLOSER IN INDIAWILL THREE LAYER DRUG TESTING RULE STRENGTHEN MEDICINE SAFETY?Heart Function may play a bigger role in Early Alzheimer's Detection than previously thought. A new study has found that even mild changes in the heart's pumping ability could predict damage in brain regions linked to Alzheimer's disease years before symptoms appear.Researchers say the findings strengthen the connection between heart health and brain health and could help doctors identify people at risk of memory decline much earlier. The study, published in the Journal of Neurology, followed 73 adults from Germany's Leipzig Heart Study over an average of 3.5 years. Researchers found that participants with lower heart pumping performance were more likely to develop microscopic tissue damage in brain areas associated with memory and thinking. POThe weight loss pills race is entering a new phase as smaller biotech companies move closer to challenging Big Pharma in the fast-growing obesity drug market. While injectable drugs have dominated obesity treatment in recent years, the focus is now shifting toward convenient oral medicines.Several emerging drugmakers have reported encouraging clinical trials results, signaling that the competition in the pharmaceutical industry is becoming more intense. The weight loss pills market is expected to expand rapidly as more companies bring oral treatments closer to commercialization. Industry experts believe oral medicines could reshape obesity treatment by offering patients a more convenient alternative to weekly injections. POAI healthcare growth is turning India into one of the world's biggest centers for medical technology innovation. The country's strong engineering talent, growing healthcare ecosystem, and focus on digital solutions are helping global companies develop advanced healthcare technologies from India. As AI healthcare growth continues to gain momentum, India is no longer seen only as a technology outsourcing destination. Instead, it is becoming a key location where global healthcare solutions are designed, tested, and improved for patients across the world. A major example of this shift comes from Philips, which revealed that more than 85 percent of its AI-powered healthcare solutions are now being developed in India. POReliance has taken another step in healthcare innovation after its subsidiary Strand Life Sciences secured an Indian patent for a blood-based test designed for early cancer detection. The patented technology uses cell-free DNA and DNA methylation analysis to identify cancer-related changes from a simple blood sample.The latest patent strengthens the company's position in precision diagnostics and could help improve access to non-invasive cancer screening in the future. The early cancer detection technology is built on a liquid biopsy platform that analyzes DNA fragments circulating in the bloodstream. Instead of relying on tissue samples, the test looks for methylation patterns linked to different types of cancer. POThe need for three-layer drug testing rises as low quality and contaminated medicines have become repeated incidents in the healthcare system in India. This leads to growing scrutiny of the system. Therefore, the need to check the quality of drugs has become stricter in the recent tragic incidents.In response to a series of maternal deaths connected with suspected drug failures, the Rajasthan government has announced a three-layer drug testing system. This is a huge change in the direction of pharmaceutical safety measures. This shift is a sign of how states are increasingly realizing the importance of ensuring the quality of medicines as well as their availability. As people rely more on public healthcare systems and free drug schemes, it is important that multi-level testing is at the heart of protecting lives. PO
< Page 7 | Page 9 >